Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06548438 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Impact of PDD During TURB for NMIBC

Study acronym: TUR_BLUE
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn if photodynamic diagnosis (PDD) performed using violet light after intra-vesical instillation of hexaminolaevulinic acid (Hexvix 85mg/50ml) is more sensitive than the standard white light tecnique in detection of malignant bladder tumour. Patients will be randomised to: * Transurethral resection of the bladder (TURB) with a standard white light tecnique * TURB with the PDD tecnique using the study drug Hexvix
Trial Details
NCT Number NCT06548438
Lead Sponsor A.O.U. Città della Salute e della Scienza
Collaborators: Photocure
Conditions
(from sponsor)		 Bladder Cancer
Related terms Urinary Bladder Neoplasms
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov